| Dec '16 | Dec '17 | Dec '18 | |
|---|---|---|---|
Current Ratio |
0.79 | 0.27 | 0.22 |
Net Debt/EBITDA |
2.18 | 2.41 | 111.92 |
Debt/Assets |
28.71% | 31.08% | 53.77% |
Debt/Equity |
0.65 | 0.88 | (148.63) |
Asset Turnover |
1.08 | 1.38 | 2.03 |
Operating CF/Net income |
(0.92) | (0.23) | 0.05 |
Capex/Depreciation |
(0.11) | (0.05) | (0.15) |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| (17.42%) | (72.88%) | (210.89%) | |
| (7.98%) | (29.76%) | (45.07%) | |
ROIC |
(8.10%) | (44.82%) | (73.72%) |
Return on Tangible Assets |
(430.95%) | 102.67% | 90.66% |
Average Days of Receivables |
8.67 | 8.76 | 9.47 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
30.51% | 33.41% | 34.49% |
Intangible Assets out of Total Assets |
0.77 | 0.75 | 0.66 |
Share Based Compensation of Revenue |
1.51% | 1.02% | 1.45% |
Graham Number |
0.00 | 0.00 | 3.01 |
Free Cash Flow per Share |
2.10 | 1.37 | (1.61) |
Cash per Share |
2.95 | 1.07 | 0.58 |
Shareholders Equity per Share |
15.56 | 7.81 | (0.05) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
15.56 | 7.81 | (0.05) |
Free Cash Flow |
57.74 | 37.71 | (44.99) |
Working Capital |
(38.25) | (261.83) | (289.22) |
Capital Expenditures |
(18.50) | (15.10) | (33.76) |
Net Current Asset Value |
(388.23) | (300.01) | (305.50) |
| Other line items | |||
Quick Ratio |
0.58 | 0.16 | 0.11 |
Depreciation/Fixed assets |
2.96 | 9.89 | 5.48 |
Cash ROIC |
2.38% | 4.37% | (23.59%) |
Accounts Receivable Turnover |
37.22 | 41.15 | 38.74 |
Accounts Payable Turnover |
9.22 | 9.59 | 9.32 |
Inventory Turnover |
27.81 | 26.79 | 25.01 |
Average Days of Payables |
36.44 | 38.14 | 39.37 |
Days of Inventory on Hand |
12.97 | 13.72 | 15.17 |
Revenue per Share |
40.83 | 39.44 | 36.26 |
Operating CF per Share |
2.77 | 1.92 | (0.40) |
Capex per Share |
(0.67) | (0.55) | (1.21) |
Average Receivables |
30.14 | 26.34 | 26.18 |
Average Payables |
76.35 | 70.37 | 70.86 |
Average Inventory |
25.30 | 25.18 | 26.40 |
Average Assets |
1,042.02 | 786.32 | 498.65 |
Average Common Equity |
477.63 | 321.13 | 106.56 |
Capex to Sales |
0.02 | 0.01 | 0.03 |
Net Profit Margin |
(7.41%) | (21.59%) | (22.16%) |
Columns are period end dates